Mind Medicine (MindMed) (MNMD) Stock Forecast & Price Target
Score
Mind Medicine (MindMed) Inc. price target
| MNMD | |
|---|---|
| Low | $14.00 |
| Average | $20.00 |
| High | $28.00 |
| Upside vs current price | -3.3% |
The average target of $20.00 is -3.3% versus the current MNMD price of $20.69.
Mind Medicine (MindMed) Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
1 analyst covers MNMD.
Mind Medicine (MindMed) Inc. EPS and revenue estimates
MNMD shows the next fiscal years with at least three analysts: 2026 EPS $-3.01, 2027 EPS $-1.76. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-3.01 | $16.67M |
| 2027 | $-1.76 | $28.45M |
Is Mind Medicine (MindMed) Inc. a buy or sell?
Of the 1 analyst covering Mind Medicine (MindMed) Inc., 1 rates it a buy (0 strong buy and 1 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The MNMD consensus label is Buy, beside 1 buy-side ratings and 0 sell-side ratings.
The average target of $20.00 implies -3.3% versus the current price of $20.69.
Those 1 ratings on MNMD are a headcount, and the label on file is Buy.
Reading the Mind Medicine (MindMed) Inc. forecast
The MNMD target range is wide: $14.00 at the low end, $20.00 in the middle, and $28.00 at the top.
Set next to the $20.69 MNMD quote, that average is -3.3%.
Ratings on the Mind Medicine (MindMed) Inc. cluster: 1 of 1 analyst is on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.
The MNMD EPS path from 2026 ($-3.01) to 2027 ($-1.76) is rising.
Only 1 analyst covers MNMD, so the average rests on a short list.
Mind Medicine (MindMed) Inc. forecast questions
What is the MNMD price target?
The published range for MNMD is $14.00 to $28.00, with an average of $20.00. That average is -3.3% versus the current price of $20.69.
Is Mind Medicine (MindMed) Inc. a buy or sell?
Of the 1 analyst covering Mind Medicine (MindMed) Inc., 1 rates it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the MNMD headcount is 1 buy, 0 hold, and 0 sell.
What is the EPS estimate for Mind Medicine (MindMed) Inc.?
Analyst EPS estimates for Mind Medicine (MindMed) Inc.: 2026 $-3.01, 2027 $-1.76.
What is the revenue estimate for Mind Medicine (MindMed) Inc.?
Analyst revenue estimates for Mind Medicine (MindMed) Inc.: 2026 $16.67M, 2027 $28.45M.
How many analysts cover MNMD?
1 analyst covers MNMD. Their consensus on MNMD is Buy, across those 1.